<DOC>
	<DOCNO>NCT00020202</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness FR901228 treat patient refractory progressive small cell lung cancer non-small cell lung cancer .</brief_summary>
	<brief_title>FR901228 Treating Patients With Refractory Progressive Small Cell Lung Cancer Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response patient refractory progressive small cell non-small cell lung cancer FR901228 . II . Determine ability FR901228 mediate apoptosis target gene induction relative tumor histology patient . III . Determine toxicity treatment patient . PROTOCOL OUTLINE : Patients stratify accord disease histology ( small cell lung cancer vs non-small cell lung cancer ) . Patients receive FR901228 IV 4 hour day 1 7 . Treatment repeat every 21 day absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 18-43 patient ( 9-21 per arm ) accrue study within 18 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Romidepsin</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Histologically cytologically confirm primary extensive stage small cell unresectable nonsmall cell lung cancer Must receive refuse prior platinumbased chemotherapy exhibit refractory progressive disease Tumor must accessible biopsy bronchoscopic percutaneous fine needle aspiration technique Measurable disease outside irradiated field document progression since irradiation Extrathoracic metastases allow No active intracranial leptomeningeal metastasis Prior surgical resection radiotherapy intracranial metastatic disease allow : No evidence active disease 2 MRI scan AND No requirement anticonvulsant medication steroid control residual symptom Prior/Concurrent Therapy Biologic therapy : At least 30 day since prior biologic therapy recover Chemotherapy : See Disease Characteristics At least 4 week since prior chemotherapy , include nitrosoureas mitomycin , recover No prior FR901228 No prior doxorubicin total dose great 450 mg/m2 Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics At least 30 day since prior radiotherapy recover At least 4 week since prior radiotherapy lung mediastinum Surgery : See Disease Characteristics Patient Characteristics Age : 18 Performance status : ECOG 02 Life expectancy : At least 3 month Hematopoietic : Platelet count least 100,000/mm3 Absolute neutrophil count least 1,500/mm3 Hepatic : PT/PTT normal Bilirubin great 1.5 mg/dL Renal : Creatinine le 1.5 mg/dL OR Creatinine clearance least 60 mL/min Cardiovascular : Ejection fraction great 40 % No unstable angina , congestive heart failure , uncontrolled cardiac dysrhythmia No deep vein thrombosis require anticoagulation Pulmonary : No pulmonary embolism within past 6 month FEV1 DLCO great 30 % predict pCO2 le 50 mm Hg room air pO2 great 60 mm Hg room air Other : HIV negative No active infection Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 6 month study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>adult solid tumor</keyword>
	<keyword>body system/site cancer</keyword>
	<keyword>cancer</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>genetic condition</keyword>
	<keyword>lung cancer</keyword>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
	<keyword>small cell lung cancer</keyword>
	<keyword>solid tumor</keyword>
	<keyword>stage III non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>stage , non-small cell lung cancer</keyword>
	<keyword>stage , small cell lung cancer</keyword>
	<keyword>thorax/respiratory cancer</keyword>
</DOC>